Blocking huntingtin oligomers from binding lipid membranes improves phenotype in a C. elegans model of Huntington's disease

被引：0
|
作者：
Siriwardhana, Chathuranga [1 ]
Legleiter, Justin A. [1 ]
机构：
[1] West Virginia Univ, Dept Chem, Morgantown, WV USA
来源：
BIOPHYSICAL JOURNAL | 2023年 / 122卷 / 03期
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
1650-Pos
引用
收藏
页码：338A / 339A
页数：2
相关论文
共 50 条
  • [21] Neuroprotective Effects of the Cultivated Chondrus crispus in a C. elegans Model of Parkinson's Disease
    Liu, Jinghua
    Banskota, Arjun H.
    Critchley, Alan T.
    Hafting, Jeff
    Prithiviraj, Balakrishnan
    MARINE DRUGS, 2015, 13 (04) : 2250 - 2266
  • [22] C. elegans as a Model Organism to Investigate Molecular Pathways Involved with Parkinson's Disease
    Harrington, Adam J.
    Hamamichi, Shusei
    Caldwell, Guy A.
    Caldwell, Kim A.
    DEVELOPMENTAL DYNAMICS, 2010, 239 (05) : 1282 - 1295
  • [23] α-Synuclein accumulates in huntingtin inclusions but forms independent filaments and its deficiency attenuates early phenotype in a mouse model of Huntington's disease
    Tomas-Zapico, Cristina
    Diez-Zaera, Maria
    Ferrer, Isidre
    Gomez-Ramos, Pilar
    Moran, Maria A.
    Teresa Miras-Portugal, M.
    Diaz-Hernandez, Miguel
    Lucas, Jose J.
    HUMAN MOLECULAR GENETICS, 2012, 21 (03) : 495 - 510
  • [24] Silencing of the Mutant Huntingtin Gene through CRISPR-Cas9 Improves the Mitochondrial Biomarkers in an In Vitro Model of Huntington's Disease
    Dunbar, Gary L.
    Koneru, Sindhuja
    Kolli, Nivya
    Sandstrom, Michael
    Maiti, Panchanan
    Rossignol, Julien
    CELL TRANSPLANTATION, 2019, 28 (04) : 460 - 463
  • [25] Loss of redoxin proteins exacerbates LRRK2-mediated Parkinson's disease phenotype in C. elegans
    Johnson, William Marshall
    Yao, Chen
    Chen, Shu
    Wilson-Delfosse, Amy L.
    Mieyal, John J.
    FASEB JOURNAL, 2013, 27
  • [26] PBT2 Reduces Toxicity in a C. elegans Model of polyQ Aggregation and Extends Lifespan, Reduces Striatal Atrophy and Improves Motor Performance in the R6/2 Mouse Model of Huntington's Disease
    Cherny, Robert A.
    Ayton, Scott
    Finkelstein, David I.
    Bush, Ashley I.
    McColl, Gawain
    Massa, Stephen M.
    JOURNAL OF HUNTINGTONS DISEASE, 2012, 1 (02) : 211 - 219
  • [27] Xyloketal-derived small molecules show protective effect by decreasing mutant Huntingtin protein aggregates in Caenorhabditis elegans model of Huntington's disease
    Zeng, Yixuan
    Guo, Wenyuan
    Xu, Guangqing
    Wang, Qinmei
    Feng, Luyang
    Long, Simei
    Liang, Fengyin
    Huang, Yi
    Lu, Xilin
    Li, Shichang
    Zhou, Jiebin
    Burgunder, Jean-Marc
    Pang, Jiyan
    Pei, Zhong
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2016, 10 : 1443 - 1451
  • [28] In Vivo Disruption of the Mutant Huntingtin Gene by CRISPR-Cas9 Improves Motor Deficits and Lifespan in a Mouse Model of Huntington's Disease
    Ekman, Freja K.
    Ojala, David J.
    Adil, Maroof
    Schaffer, David V.
    Gaj, Thomas
    MOLECULAR THERAPY, 2018, 26 (05) : 401 - 401
  • [29] Endogenous metabolites rescue a C. elegans model of Alzheimer's disease by triggering a heat shock response
    Joshi, P.
    Perni, M.
    Limbocker, R.
    Mannini, B.
    Casford, S.
    Chia, S.
    Labbadia, J.
    Dobson, C.
    Vendruscolo, M.
    FEBS OPEN BIO, 2019, 9 : 225 - 225
  • [30] Neurorescue Effects of Frondoside A and Ginsenoside Rg3 in C. elegans Model of Parkinson's Disease
    Chalorak, Pawanrat
    Sanguanphun, Tanatcha
    Limboonreung, Tanapol
    Meemon, Krai
    MOLECULES, 2021, 26 (16):
12345